Phase I trial to determine the safety, pharmacodynamics, and pharmacokinetics of RSR13, a novel radioenhancer, in newly diagnosed glioblastoma multiforme

Lawrence Kleinberg, S. A. Grossman, Steven Piantadosi, J. Pearlman, H. Engelhard, G. Lesser, J. Ruffer, M. Gerber

Research output: Contribution to journal › Article › peer-review

34 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I trial to determine the safety, pharmacodynamics, and pharmacokinetics of RSR13, a novel radioenhancer, in newly diagnosed glioblastoma multiforme'. Together they form a unique fingerprint.

Medicine & Life Sciences